Ultimele actualizari :
Stabilitatea si compatibilitatea medicamentelor
Bine ati venit pe site-ul Stabilis. Daca doriti sa primiti ultimele noutati, trimiteti-ne adresa mail.

Pentru intrebari sau comentarii, contactati infostab@stabilis.org
Baze de date  
Bibiografie : 2156
Molecula (substanta activa) : 770
Clasa farmacologica : 40
Stabilitatea solutiilor : 4743
Stabilitatea in amestec : 1015
Incompatibilitati : 2972
Denumirea comerciala : 1964
Noutati - Molecula (substanta activa)  
Vasodilatator Injectabil Dipyridamol 10/06/2017
Antiepileptic Unguente Gabapentine 06/06/2017
Antidepresiv Unguente Amitriptyline 06/06/2017
Diverse Unguente Baclofen 06/06/2017
Antiinflamator Unguente Ketoprofen 06/06/2017
Antiviral Aerosol Ribavirine 03/03/2017
Citostatic Injectabil Necitumumab 31/01/2017
Diverse Injectabil Belimumab 24/01/2017
Hipoglicemiant Injectabil Insulin glulisine 24/01/2017
Diverse Injectabil Zoledronic acid 24/01/2017
Antidot Injectabil Hydroxocobalamin 24/01/2017
Diverse Injectabil Trimebutine 24/01/2017
Diverse Injectabil Indocyanine green 24/01/2017
Stimulant respirator Soluţie orală Caffeine 23/01/2017
Antiinflamator Soluţie orală Naproxen 22/01/2017
Antidepresiv Soluţie orală Sertraline hydrochloride 22/01/2017
Antiemetic Soluţie orală Domperidone 22/01/2017
Antiepileptic Soluţie orală Carbamazepine 22/01/2017
Diverse Soluţie orală Allopurinol 22/01/2017
Antidepresiv Soluţie orală Clomipramine 22/01/2017
Noutati - Bibiografie  
Data de intrare
3984 Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water. Hosp Pharm 16/05/2017
3985 Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : évaluation in-vitro. Hopipharm Congress 2017 - Nancy 16/05/2017
3974 Stability of frozen 1% voriconazole eye drops in glass and in innovative containers. EAHP congress - Cannes 2017 18/04/2017
3975 Stability of 50 and 100µg/0,1mL intraocular solutions of voriconazole at 2-8°C. EAHP congress - Cannes 2017 18/04/2017
3976 Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. EAHP congress - Cannes 2017 18/04/2017
3969 Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems. Neuromodulation 07/04/2017
3961 Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 03/04/2017
3963 Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions. Int J Pharm Compound 03/04/2017
3964 Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 03/04/2017
3951 Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C Hemodial Int 14/03/2017
3952 Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C. Hemodial Int 14/03/2017
3953 In vitro stability and compatibility of tenecteplase in central venous access devices. Hemodial Int 14/03/2017
3956 Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique. ASAIO Journal 14/03/2017
3958 A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities . J Infect Dis 14/03/2017
3948 Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 08/03/2017
3945 Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags. Can J Hosp Pharm 06/03/2017
3946 Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes Can J Hosp Pharm 06/03/2017
3941 Nicardipine - Summary of Product Characteristics Concordia International 21/02/2017
3938 Necitumumab (Portrazza®) – Résumé des caractéristiques du produits Lilly S.A 31/01/2017
3937 Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 30/01/2017
3930 Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit Serb laboratoire 24/01/2017
3931 Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 24/01/2017
3932 Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 24/01/2017
3933 Acide zolédronique - (Acide zoledronique Teva Pharma®) - Résumé des caractéristiques du produit Teva Laboratoire 24/01/2017
3934 Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 24/01/2017
3935 Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit Sanofi Laboratoire 24/01/2017
3936 Bélimumab (Benlysta®) – Résumé des caractéristiques du produits GlaxoSmithKline Laboratoire 24/01/2017
3923 Stability of sildenafil in combination with heparin and dopamine. Am J Health-Syst Pharm 05/01/2017
3924 One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 05/01/2017
3925 Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C. Ann Pharm Fr 05/01/2017

Temps de calcul serveur : 117 millisecondes